BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19098857)

  • 21. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
    Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
    Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased CD64 expression on polymorphonuclear neutrophils indicates infectious complications following solid organ transplantation.
    Grey D; Sack U; Scholz M; Knaack H; Fricke S; Oppel C; Luderer D; Fangmann J; Emmrich F; Kamprad M
    Cytometry A; 2011 Jun; 79(6):446-60. PubMed ID: 21472846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Kayazawa M; Saitoh O; Kojima K; Nakagawa K; Tanaka S; Tabata K; Matsuse R; Uchida K; Hoshimoto M; Hirata I; Katsu K
    Am J Gastroenterol; 2002 Feb; 97(2):360-9. PubMed ID: 11866274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
    Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery.
    Fjaertoft G; Håkansson LD; Pauksens K; Sisask G; Venge P
    Scand J Infect Dis; 2007; 39(6-7):525-35. PubMed ID: 17577814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease.
    Farhadi A; Keshavarzian A; Fields JZ; Jakate S; Shaikh M; Banan A
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2338-43. PubMed ID: 17645464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.
    Minar P; Haberman Y; Jurickova I; Wen T; Rothenberg ME; Kim MO; Saeed SA; Baldassano RN; Stephens M; Markowitz J; Rosh J; Crandall WV; Heyman MB; Mack DR; Griffiths AM; Baker SS; Hyams JS; Kugathasan S; Denson LA
    Inflamm Bowel Dis; 2014 Jun; 20(6):1037-48. PubMed ID: 24788216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection.
    Folwaczny C; Loeschke K; Schnettler D; Jäger G; Wiebecke B; Hoelscher M; Sauer T; König A; Endres SP; Fricke H
    Clin Immunol; 2000 Jun; 95(3):197-202. PubMed ID: 10866126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis.
    Livaditi O; Kotanidou A; Psarra A; Dimopoulou I; Sotiropoulou C; Augustatou K; Papasteriades C; Armaganidis A; Roussos C; Orfanos SE; Douzinas EE
    Cytokine; 2006 Dec; 36(5-6):283-90. PubMed ID: 17368039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of neutrophil CD64 expression, manual myeloid immaturity counts, and automated hematology analyzer flags as indicators of infection or sepsis.
    Davis BH; Bigelow NC
    Lab Hematol; 2005; 11(2):137-47. PubMed ID: 16024338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced intestinal expression of the proteasome subunit low molecular mass polypeptide 2 in patients with inflammatory bowel disease.
    Fitzpatrick LR; Small JS; Poritz LS; McKenna KJ; Koltun WA
    Dis Colon Rectum; 2007 Mar; 50(3):337-48; discussion 348-50. PubMed ID: 17160513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation.
    Song SH; Kim HK; Park MH; Cho HI
    Thromb Res; 2008; 121(4):499-507. PubMed ID: 17597188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of endothelial dysfunction in patients with inflammatory bowel disease.
    Roifman I; Sun YC; Fedwick JP; Panaccione R; Buret AG; Liu H; Rostom A; Anderson TJ; Beck PL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):175-82. PubMed ID: 19121648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel applications of the quantitative analysis of neutrophil cell surface FcgammaRI (CD64) to the diagnosis of infectious and inflammatory diseases.
    Nuutila J
    Curr Opin Infect Dis; 2010 Jun; 23(3):268-74. PubMed ID: 20407370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage.
    Foell D; Wittkowski H; Roth J
    Gut; 2009 Jun; 58(6):859-68. PubMed ID: 19136508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease.
    Thakkar K; Lucia CJ; Ferry GD; McDuffie A; Watson K; Tsou M; Gilger MA
    Am J Gastroenterol; 2009 Mar; 104(3):722-7. PubMed ID: 19209163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.